Moreover, we proposed that OCT4 functions as both a tumour suppressor and a tumour promoter, mediating tumour suppressor functions in early tumorigenesis and ERα‐positive breast cancer progression, and tumour promoter functions in ERα‐negative breast cancer progression. The gene discussed is ESR1; the disease is breast carcinoma.